The economic benefits of reducing cardiovascular disease mortality in Quebec, Canada
Authors: David Boisclair, Yann Décarie, François Laliberté-Auger, Pierre-Carl Michaud, and Carole Vincent
Objectives We assess how different scenarios of cardiovascular disease (CVD) prevention, aimed at meeting targets set by the World Health Organization (WHO) for 2025), may impact healthcare spending in Quebec, Canada over the 2050 horizon. Methods We provide long-term forecasts of healthcare use and costs at the Quebec population level using a novel dynamic microsimulation model. Using both survey and administrative data, we simulate the evolution of the Quebec population’s health status until death, through a series of dynamic transitions that accounts for social and demographic characteristics associated with CVD risk factors. Results A 25% reduction in CVD mortality between 2012 and 2025 achieved through decreased incidence could contain the pace of healthcare cost growth towards 2050 by nearly 7 percentage points for consultations with a physician, and by almost 9 percentage points for hospitalizations. Over the 2012-2050 period, the present value of cost savings is projected to amount to C$13.1 billion in 2012 dollars. The years of life saved due to improved life expectancy could be worth another C$38.2 billion. Addressing CVD mortality directly instead would bring about higher healthcare costs, but would generate more value in terms of years of life saved, at C$69.6 billion. Conclusions Potential savings associated with plausible reductions in CVD, aimed at reaching a World Health Organization target over a 12-year period, are sizeable and may help address challenges associated with an aging population.
Please note that abstracts only appear in the language of the publication and might not have a translation.
|Author||David Boisclair, Yann Décarie, François Laliberté-Auger, Pierre-Carl Michaud, and Carole Vincent|
|Title||The economic benefits of reducing cardiovascular disease mortality in Quebec, Canada|
|Journal Name||PLoS ONE|
- David Boisclair
- David Boisclair, Yann Décarie, François Laliberté-Auger, Pierre-Carl Michaud, and Carole Vincent
- The economic benefits of reducing cardiovascular disease mortality in Quebec, Canada
- PLoS ONE
Lauren E. Wallar and Laura C. Rosella (2020).
Risk factors for avoidable hospitalizations in Canada using national linked data: A retrospective cohort study
PLoS One , 21-Jan
John P. Ekwaru, Arto Ohinmaa, Bach X. Tran, Solmaz Setayeshgar, Jeffrey A. Johnson, and Paul J. Veugelers (2017).
Cost-effectiveness of a school-based health promotion program in Canada: A life-course modeling approach
PLoS ONE , 13-Jan
Ashley McAllister, Theo Bodin, Henrik Brønnum-Hansen, Lisa Harber-Aschan, Ben Barr, Lee Bentley, Qing Liao, Natasja Koitzsch Jensen, Ingelise Andersen, Wen-Hao Chen, Karsten Thielen, Cameron Mustard, Finn Diderichsen, Margaret Whitehead, and Bo Burström (2020).
Inequalities in extending working lives beyond age 60 in Canada, Denmark, Sweden and England - By gender, level of education and health
PLoS ONE , e0234900
Karen M. Davison, Cliff Holloway, Lovedeep Gondara, and Anne S. Hatcher (2018).
Independent associations and effect modification between lifetime substance use and recent mood disorder diagnosis with household food insecurity
PLoS ONE , 14-Jan
Smriti Singh, James Ted McDonald, Gabriela Ilie, and Anil Adisesh (2020).
An examination of the association between lifetime history of prostate and pancreatic cancer diagnosis and occupation in a population sample of Canadians
PLOS One , 17-Jan
Paquito Bernard, Isabelle Doré, Ahmed-Jérôme Romain, Gabriel Hains-Monfette, Celia Kingsbury, and Catherine Sabiston (2018).
Dose response association of objective physical activity with mental health in a representative national sample of adults: A cross-sectional study
PLoS ONE , 16-Jan
Shicheng Jin, Graham E. Trope, Yvonne M. Buys, Elizabeth M. Badley, Kednapa Thavorn, Peng Yan, Harrish Nithianandan, and Ya-Ping Jin (2019).
Reduced social participation among seniors with self-reported visual impairment and glaucoma
PLOS ONE , 16-Jan